asa guidelines for glp 1 drugs A narrative review of glucagon-like peptide-1 receptor agonists prior to deep sedation or general anesthesia Perioperative Management of GLP-1 RAs
Description
Mctabi and Dr
This prolonged half-life permits reduced injection frequency compared to conventional GLP-1 analogs, offering improved patient adherence and sustained glycemic control [29]
Methods GLP-1 agonists included in the analysis were approved for treatment of obesity (Saxenda, Wegovy, Zepbound) and corresponding formulations that may potentially be used off-label for treatment of obesity (Mounjaro, Ozempic, Rybelsus, Victoza)
The beneficial effects of GLP-1 receptor activation on glycemia occur through several mechanisms: GLP-1 stimulates glucose-dependent insulin secretion from pancreatic -cells, suppresses inappropriately elevated glucagon secretion from pancreatic -cells, delays gastric emptying, and induces satiety via a direct action in the central nervous system
Alcohol is one of the most common causes of pancreatitis, Johnson-Rabbett adds
